Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anu Venkatesh

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|February 6, 2014
Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classificationKensuke Kojima, Craig April, Claudia Canasto-Chibuque, et al.
Gut|November 17, 2016
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaJulien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Gut|August 22, 2014
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationLindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|February 6, 2014
Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classificationKensuke Kojima, Craig April, Claudia Canasto-Chibuque, et al.
Gut|November 17, 2016
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaJulien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2016
Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agentsHuagang Lu, John Rogowskyj, Wenquan Yu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
Clinicopathological indices to predict hepatocellular carcinoma molecular classificationPoh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, et al.
Experimental & Molecular Medicine|November 18, 2017
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseasesRuchi Bansal, Shigeki Nakagawa, Saleh Yazdani, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Gut|August 22, 2014
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationLindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Nature Communications|September 18, 2021
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discoveryEmilie Crouchet, Simonetta Bandiera, Naoto Fujiwara, et al.
Pageof 2